Aldevron co-founder named to board of MIT's Whitehead Institute

Michael Chambers is the founding CEO of Aldevron, a Fargo biotechnology firm. The Whitehead Institute is a nonprofit biomedical research institution.

Michael Chambers
Michael Chambers.
Submitted photo
We are part of The Trust Project.

FARGO — Michael Chambers, the founding CEO of Aldevron, has been elected to the board of directors for the Whitehead Institute at the Massachusetts Institute of Technology.

The Whitehead Institute is a nonprofit biomedical research center in Cambridge, Massachusetts.

Chambers is one of two new members elected to a six-year term on the board that were announced on Thursday, Dec. 8.

The Whitehead Institute specializes in basic research that solves "deep scientific mysteries underlying many diseases, leading to new approaches in medicine," according to its website.

Chambers co-founded Aldevron in 1998. The firm makes custom materials, including DNA and proteins, used in biotechnology and biopharmaceuticals. Aldevron was acquired by Dannaher for $9.6 billion in 2021.

What To Read Next
City is offering the Moorhead-based craft brewery a package of property tax breaks and economic development funds that approaches $700,000.
American Crystal Sugar, based in Moorhead, said sugarbeet farmers in Montana showed there no longer was adequate interest in growing enough of the crop to sustain operations.
Anthony Reese Jr. was sentenced to life without parole for fatally shooting Richard Pittman and April Carbone. Carbone was eight months pregnant with a girl she and Pittman planned to name Layla.
Native American activist Leonard Peltier was convicted for his part in the deaths of two FBI agents in 1977 and is serving two consecutive life sentences.